Effective, efficient drug development is essential to reach more patients, faster. Samit Hirawat, Chief Medical Officer, joined Fortune Brainstorm Health 2022 to discuss how BMS is making industry-leading changes to the drug development process, transforming clinical trials to increase patient engagement and grow trial diversity, as well as utilizing the latest advancements in AI, machine learning and big data to help accelerate the development of new medicines for patients in need.

свернуть